Vivos (RDGL) EPS (Diluted) Growth (1y) (2012 - 2025)
Vivos (RDGL) EPS (Diluted) Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -29.80% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 95.96% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 114.19% |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 4.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.62% |
| Sep 30, 2025 | 43.36% |
| Jun 30, 2025 | -14.04% |
| Mar 31, 2025 | -29.83% |
| Dec 31, 2024 | 14.41% |
| Sep 30, 2024 | -9.40% |
| Jun 30, 2024 | 49.09% |
| Mar 31, 2024 | -109.41% |
| Dec 31, 2023 | -45.33% |
| Sep 30, 2023 | -123.66% |
| Jun 30, 2023 | -7.05% |
| Mar 31, 2023 | -1,257.35% |
| Dec 31, 2022 | -15,526.29% |
| Sep 30, 2022 | -5,454.93% |
| Jun 30, 2022 | -1,607.47% |
| Mar 31, 2022 | -142.86% |
| Dec 31, 2021 | 41.00% |
| Sep 30, 2021 | -48.36% |
| Jun 30, 2021 | -1,069.29% |
| Mar 31, 2021 | 20.00% |